Filter Results
Clinical Studies
Results filtered:Study status:
Closed for Enrollment
Closed for Enrollment
-
(RTMPE for CAV) Real Time Myocardial Perfusion Echocardiography for Detection of Coronary Allograft Vasculopathy in Cardiac Transplant Patients
Rochester, Minn.
The purpose of this study is to see if the use of real time ultrasound of heart muscle perfusion is a usable and effective non-invasive way to detect Coronary Allograft Vasculopathy (heart transplant caused blood vessel disease) in child and adult heart transplant patients.
-
A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319
Rochester, Minn.
The purpose of this study is to evaluate long-term safety and tolerability data in eligible CLCZ696B2319 (PANORAMA-HF) pediatric patients receiving open-label sacubitril/valsartan.
-
A Multicenter, Open-label, Randomized, Event-driven Study to Assess Efficacy, Safety and Pharmacokinetics of Macitentan Versus Standard of Care in Children With Pulmonary Arterial Hypertension (TOMORROW)
Rochester, Minn.
This is a prospective, multicenter, open-label, randomized, controlled, parallel group, group-sequential, event-driven Phase 3 study to evaluate efficacy, safety and pharmacokinetics (PK) of macitentan in children.
-
Adapting a Measure of Heart Failure to an Adolescent Population
Rochester, Minn.
The purpose of this study is to understand the experience of heart failure symptoms on the adolescent patient population, including the impact of symptoms on quality of life and wellbeing.
-
Growth, Development and Quality of Life in Pediatric Patients after Cone Reconstruction for Ebstein Anomaly
Rochester, Minn.
In this study, we seek to perform a survey of patients who had surgery performed at Mayo Clinic for Ebstein's anomaly, asking for growth charts when available, and giving patients a limited developmental screening questionnaire and quality of life questionnaire. We seek to try to determine the specific age at which repair of Ebstein's anomaly may result in improved long-term outcomes beyond the operating room.
-
Multicenter, Open-label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LCZ696 Followed by a 52-week Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared With Enalapril in Pediatric Patients From 1 Month to 18 Years of Age With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction
Rochester, Minn.
This study consist of two parts (Part 1 and Part 2). The purpose of Part 1 is to evaluate the way the body absorbs, distributes and removes the drug LCZ696. This will help determine the proper dose of LCZ696 for Part 2 of the study. The purpose for Part 2 is to compare the effectiveness and safety of LCZ696 with enalapril in pediatric heart failure patients over 52 weeks of treatment.
.